Cell death proteins in sepsis: key players and modern therapeutic approaches

Cell death proteins play a central role in host immune signaling during sepsis. These interconnected mechanisms trigger cell demise via apoptosis, necroptosis, and pyroptosis while also driving inflammatory signaling. Targeting cell death mediators with novel therapies may correct the dysregulated inflammation seen during sepsis and improve outcomes for septic patients.

• Publication year

  2024

• Venue

  Frontiers in Immunology

• Publication date

  2024-01-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fimmu.2023.1347401PMID 38274794PMCID 10808706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death

  2023cited by this paper
• CRISPR/Cas9 therapeutics: progress and prospects

  2023cited by this paper
• mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications

  2023cited by this paper
• A necroptosis-independent function of RIPK3 promotes immune dysfunction and prevents control of chronic LCMV infection

  2023cited by this paper
• Cell-Free DNA as Biomarker for Sepsis by Integration of Microbial and Host Information.

  2022cited by this paper
• Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung

  2022cited by this paper
• RIP3 knockdown inhibits necroptosis of human intestinal epithelial cells via TLR4/MyD88/NF-κB signaling and ameliorates murine colitis

  2022cited by this paper
• Repositioning linifanib as a potent anti-necroptosis agent for sepsis

  2022influential reference
• The RIPK3 Scaffold Regulates Lung Inflammation During Pseudomonas Aeruginosa Pneumonia.

  2022cited by this paper
• Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis

  2022cited by this paper
• Robust, Durable Gene Activation In Vivo via mRNA-Encoded Activators

  2022cited by this paper
• A long way to go: caspase inhibitors in clinical use

  2021influential reference
• Microneedle-assisted genome editing: A transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders

  2021cited by this paper
• Necroptosis, pyroptosis and apoptosis: an intricate game of cell death

  2021cited by this paper
• MLKL: Functions beyond serving as the Executioner of Necroptosis

  2021cited by this paper
• The growth of siRNA-based therapeutics: updated clinical studies.

  2021cited by this paper
• Distinct cell death markers identified in critical care patient survivors diagnosed with sepsis.

  2021cited by this paper
• Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents

  2021cited by this paper
• Necroptosis Underlies Hepatic Damage in a Piglet Model of Lipopolysaccharide-Induced Sepsis

  2021cited by this paper
• The cGAS–STING pathway as a therapeutic target in inflammatory diseases

  2021cited by this paper
• The Role and Mechanism of Pyroptosis and Potential Therapeutic Targets in Sepsis: A Review

  2021cited by this paper
• Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers

  2020cited by this paper
• Sequential changes of NLRP3 inflammasome activation in sepsis and its relationship with death.

  2020cited by this paper
• Toll-like Receptors and the Control of Immunity.

  2020cited by this paper
• Molecular mechanisms and cellular functions of cGAS–STING signalling

  2020cited by this paper
• Inflammasome activation and regulation: toward a better understanding of complex mechanisms

  2020cited by this paper
• PANoptosis in microbial infection

  2020cited by this paper
• Indirect regulation of HMGB1 release by gasdermin D

  2020cited by this paper
• Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications

  2020cited by this paper
• An overview of the non-canonical inflammasome.

  2020cited by this paper
• Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

  2019cited by this paper
• The current state and future directions of RNAi-based therapeutics

  2019cited by this paper
• Necrostatin-1 accelerates time to death in a rat model of cecal ligation and puncture and massively increases hepatocyte caspase-3 cleavage.

  2019cited by this paper
• Heterogeneity in sepsis: new biological evidence with clinical applications

  2019cited by this paper
• Nlrp3 inflammasome activation and Gasdermin D-driven pyroptosis are immunopathogenic upon gastrointestinal norovirus infection

  2019cited by this paper
• Caspases in Cell Death, Inflammation, and Disease.

  2019cited by this paper
• Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke via Inhibition of RIPK1-Mediated RIPK3/MLKL Signaling

  2019cited by this paper
• Plasma receptor interacting protein kinase-3 levels are associated with acute respiratory distress syndrome in sepsis and trauma: a cohort study

  2019cited by this paper
• DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer

  2019cited by this paper
• Gasdermin D Exerts Anti-inflammatory Effects by Promoting Neutrophil Death

  2018cited by this paper
• Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters

  2018cited by this paper
• RIPK3 promotes sepsis-induced acute kidney injury via mitochondrial dysfunction.

  2018cited by this paper
• Gasdermin D Promotes AIM2 Inflammasome Activation and Is Required for Host Protection against Francisella novicida

  2018cited by this paper
• CpG-DNA exerts antibacterial effects by protecting immune cells and producing bacteria-reactive antibodies

  2018cited by this paper
• The CRISPR tool kit for genome editing and beyond

  2018cited by this paper
• Noncanonical inflammasome signaling elicits gasdermin D–dependent neutrophil extracellular traps

  2018cited by this paper
• Molecular Mechanisms and Biological Functions of siRNA

  2017cited by this paper
• Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3

  2017cited by this paper
• Programmed cell death and the immune system

  2017cited by this paper
• Alternative inflammasome activation enables IL-1β release from living cells.

  2017cited by this paper
• ZBP1: Innate Sensor Regulating Cell Death and Inflammation.

  2017cited by this paper
• Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways

  2017cited by this paper
• RIPK3 in cell death and inflammation: the good, the bad, and the ugly

  2017cited by this paper
• Caspase‐8: regulating life and death

  2017cited by this paper
• EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation

  2017cited by this paper
• Deletion of Nlrp3 Augments Survival during Polymicrobial Sepsis by Decreasing Autophagy and Enhancing Phagocytosis

  2017cited by this paper
• Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.

  2017cited by this paper
• Caspases and their substrates

  2017cited by this paper
• The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups

  2017cited by this paper
• Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non‐survivors

  2017cited by this paper
• The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection

  2017cited by this paper
• Mitochondrial DNA in Sepsis

  2017cited by this paper
• Inflammasomes: mechanism of assembly, regulation and signalling

  2016influential reference
• Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study

  2016cited by this paper
• SESN2/sestrin2 suppresses sepsis by inducing mitophagy and inhibiting NLRP3 activation in macrophages

  2016cited by this paper
• The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties

  2015cited by this paper
• Redefining the gut as the motor of critical illness.

  2014cited by this paper
• mRNA-based therapeutics — developing a new class of drugs

  2014cited by this paper
• Liposomal siRNA nanocarriers for cancer therapy.

  2014cited by this paper
• Inflammatory caspases are innate immune receptors for intracellular LPS

  2014cited by this paper
• Development and applications of CRISPR-Cas9 for genome engineering.

  2014cited by this paper
• RIP3 induces apoptosis independent of pronecrotic kinase activity.

  2014cited by this paper
• True Grit: Programmed Necrosis in Antiviral Host Defense, Inflammation, and Immunogenicity

  2014cited by this paper
• Necroptosis.

  2014cited by this paper
• Necroptosis: the release of damage-associated molecular patterns and its physiological relevance.

  2013cited by this paper
• Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL*

  2013cited by this paper
• RNA‐based mechanisms regulating host–virus interactions

  2013cited by this paper
• Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models

  2012cited by this paper
• DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA.

  2012cited by this paper
• Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model

  2012cited by this paper
• RIP3 mediates the embryonic lethality of caspase-8-deficient mice

  2011cited by this paper
• TARGETED DELIVERY OF siRNA TO CELL DEATH PROTEINS IN SEPSIS

  2009cited by this paper
• BIM siRNA DECREASES LYMPHOCYTE APOPTOSIS AND IMPROVES SURVIVAL IN SEPSIS

  2008cited by this paper
• Local thymic caspase-9 inhibition improves survival during polymicrobial sepsis in mice

  2006cited by this paper
• In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice.

  2005cited by this paper
• Akt Decreases Lymphocyte Apoptosis and Improves Survival in Sepsis1

  2004cited by this paper
• Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis.

  2002cited by this paper
• Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte

  2000cited by this paper
• Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction.

  1999cited by this paper
• Prevention of lymphocyte cell death in sepsis improves survival in mice.

  1999cited by this paper
• Progress and Prospects

  1991cited by this paper
• Brief Definitive Report Toll-like Receptor 9 Inhibition Reduces Mortality in Polymicrobial Sepsis

  year unknowncited by this paper

• Sepsis.

  2026cites this paper
• Programmed cell death markers in COVID-19 survivors with and without sepsis

  2025cites this paper
• Leveraging diverse cell-death patterns in diagnosis of sepsis by integrating bioinformatics and machine learning

  2025cites this paper
• FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death

  2025cites this paper
• ALA Alleviates Liver Damage in Septic Mice Through PI3K/AKT Signaling Pathway

  2025cites this paper
• Role of Endoplasmic Reticulum Stress-Associated Genes in Septic Neonatal Foals

  2025cites this paper
• From Molecular Mechanisms of the Pathogenesis of Sepsis to the Novel Healing Biomolecules: Recent Progressions in Dealing With Sepsis

  2025cites this paper
• Cell death signaling and immune regulation: new perspectives on targeted therapy for sepsis

  2025cites this paper
• Potential of biomarker-based enrichment strategies to identify critically ill patients for emerging cell death interventions

  2025cites this paper
• Recent Insights into the Evolving Role of the Gut Microbiome in Critical Care.

  2024cites this paper
• Mechanism of Sepsis

  year unknowncites this paper